ACE-Inhibition and Angiotensin II Receptor Blockers in Chronic Heart Failure: Pathophysiological Consideration of the Unresolved Battle
Authors:
- 1 May 2003
- journal article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 17 (3) , 287-290
Abstract
Reducing the effects of angiotensin II by blockade of AT1-receptors may be superior to inhibition of angiotensin II formation by angiotensin converting enzyme (ACE) inhibitors in chronic heart...Keywords
This publication has 25 references indexed in Scilit:
- Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trialThe Lancet, 2002
- Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trialsJACC, 2002
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryThe Journal of Heart and Lung Transplantation, 2002
- Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failureJACC, 2002
- The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint dataThe American Journal of Cardiology, 2001
- Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE IIThe Lancet, 2000
- Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and designJournal of Cardiac Failure, 1999
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- ?Escape? of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: Implications for therapyCardiovascular Drugs and Therapy, 1995
- Connective tissue: a metabolic Entity?Journal of Molecular and Cellular Cardiology, 1995